Cipla Asthalin 2.5mg/2.5ml Respules

Cipla Asthalin 2.5mg/2.5ml Respules contain salbutamol 2.5mg in 2.5ml of nebulizer solution, a short-acting beta2-agonist (SABA) bronchodilator supplied in single-dose vials (respules) for use with a nebulizer machine. It is used for the relief of acute asthma attacks, COPD exacerbations, and other conditions causing bronchospasm, particularly when a more sustained or higher-volume dose of bronchodilator is needed than a handheld inhaler can conveniently provide.

As a nebulizer solution intended for use only with a nebulizer device, Cipla Asthalin 2.5mg/2.5ml Respules is a prescription-only medicine in Malaysia and Singapore. An online consultation through DoctorOnCall is required so a doctor can confirm the diagnosis, appropriate dose, and correct nebulizer technique; this product is not for oral or injectable use and must never be swallowed or injected.

Salbutamol selectively stimulates beta2-adrenergic receptors in the smooth muscle lining the airways, causing the muscles around the bronchi to relax and the airways to widen; when delivered via a nebulizer, the medicine is converted into a fine mist that is breathed in directly into the lungs over several minutes, providing effective bronchodilation for more significant or acute breathing difficulty.

Use only with a nebulizer machine as directed by your doctor; twist or snap open the respule as instructed, empty the entire contents into the nebulizer chamber (diluting with saline first only if your doctor has told you to), attach the mouthpiece or mask, and breathe the mist in through the mouth over the recommended time until the chamber is empty. Do not swallow or inject the solution.

The typical dose is one 2.5mg/2.5ml respule nebulized as needed, or as prescribed by your doctor, which may adjust the frequency and strength based on the severity of your symptoms; do not exceed the frequency your doctor has advised, and seek urgent medical attention if symptoms do not improve or worsen despite nebulization.

Cipla Asthalin 2.5mg/2.5ml Respules are generally stable for up to 24 months from manufacture when stored correctly and unopened; check the expiry date on the foil strip or carton, and use each respule immediately once opened, discarding any unused portion.

Store the respules below 25°C (or as specified on the packaging), protected from light, in their original foil strip until ready to use, and keep out of reach of children.

• Known hypersensitivity to salbutamol or any other ingredient in the solution
• Caution required in people with significant heart rhythm problems, uncontrolled heart disease, or thyrotoxicosis
• Not for oral or injectable use under any circumstances
• Not a substitute for anti-inflammatory (preventer) treatment in persistent asthma; overuse without proper monitoring can mask worsening disease
• Caution in people with poorly controlled diabetes, as beta2-agonists can affect blood glucose and potassium

• Beta-blockers may reduce the effectiveness of salbutamol and can trigger bronchospasm in susceptible individuals
• Other bronchodilators or stimulant medicines used together may increase the risk of tremor and palpitations
• Diuretics may increase the risk of low blood potassium when combined with salbutamol
• Certain antidepressants (MAOIs, tricyclics) may increase cardiovascular side effects

• Use only with a properly maintained nebulizer machine, never take the solution by mouth or by injection
• Clean and dry your nebulizer equipment after each use as per the manufacturer’s instructions to prevent contamination
• Do not dilute the respule unless your doctor has specifically told you to
• Seek urgent medical attention if breathing difficulty does not improve after nebulization
• Keep a record of how often you need to use it and share this with your doctor at follow-up

Cipla Asthalin 2.5mg/2.5ml Respules are intended for nebulizer use in the relief of acute or more significant bronchospasm rather than for routine daily control, and increasing or frequent need for nebulization should prompt urgent medical review rather than repeated self-treatment at home.